HOME >> MEDICINE >> NEWS
Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study

HOUSTON - The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.

The risk was first discovered and reported last September by the study's safety monitoring board and led to the shutdown of the colon cancer chemoprevention trial and subsequent withdrawal of the drug from the U.S. market.

The trial, known as APPROVe (Adenomatous Polyp Prevention on Vioxx), was the longest test yet of Vioxx as a chemoprevention agent, and was designed to determine whether the drug could prevent the re-growth of precancerous colon polyps in people who had already had polyps removed. The prospective chemoprevention study randomized 2,586 participants from 108 centers in 29 countries to receive either 25 mgs. of Vioxx daily or a placebo drug for three years, 2001-2004. The trial was stopped September 30, 2004 - approximately two months before its planned completion.

According to Robert S. Bresalier, M.D., of The University of Texas M. D. Anderson Cancer Center and lead author of The New England Journal of Medicine study, 46 of the 1287 patients randomized to take Vioxx daily had confirmed cardiovascular events over a three year period - mostly heart attacks or strokes. In the 1,299 patients given a placebo drug, there were 26 events. Each group, however, had the same number of deaths and not all were related to heart attacks or strokes.

"The overall number of cardiovascular events is small, but, nevertheless, the difference between the groups is significant," says Bresalier, who is professor and chair of the Department of Gastrointestinal Medicine and Nutrition at M. D. Anderson and a member of the study's steering committee.

This study
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
15-Feb-2005


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers offer emergency workers a lifeline
8. Researchers discover genetic variant that may explain why women develop M.S. more than men
9. Researchers map the sexual network of an entire high school
10. Researchers hope monkeys can provide new insights into depression
11. Researchers identify the link between heart failure and weight loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... ... January 23, 2020 , ... The Mount Sinai Health System ... research firm Statista. , Mount Sinai was ranked No. 3 in the “Healthcare & ... The Health System is New York City’s largest academic medical system, including eight hospitals, ...
(Date:1/23/2020)... ... ... A January 7 article from Good Housekeeping details the possible ... the president of the American Society of Plastic Surgeons who says that the causes ... person’s facial structure including an undefined jawline, a loss of elasticity in the skin, ...
(Date:1/23/2020)... ... 23, 2020 , ... The Muscogee (Creek) Nation Department of ... in Tulsa, to provide patients with unprecedented access to Chronic Obstructive Pulmonary Disease ... HGE Health’s digital symptom management platform, which allows RespirCare to proactively reach out ...
(Date:1/23/2020)... , ... January 23, 2020 , ... ... living with memory impairment, has announced the Best Memory Care Facilities in Santa ... to experts, facility features and amenities. , According to the Alzheimer’s ...
(Date:1/23/2020)... ... January 23, 2020 , ... MemoryCare.com , a ... the Best Memory Care Facilities in Pensacola, Florida. The guide identifies 7 memory ... , According to the Alzheimer’s Association , 5.6 million people age 65 ...
Breaking Medicine News(10 mins):
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... Please join ... she begins her term as the Society’s president for 2020. Dr. Dorbala is the ... and is an associate professor of radiology at Harvard. Over more than 20 years ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... Inc. 5000 fastest growing company, today announced a strategic partnership with the Idaho ... , Through this partnership, Aeroflow Healthcare will provide IPN patients with its full ...
(Date:1/22/2020)... ... January 22, 2020 , ... Natreon, a nutritional ingredient ... Terminalia chebula. This newly granted patent expands Natreon’s strong patent portfolio to a total ... primary claim in this patent is, “a method of treating osteoarthritis in a mammal, ...
Breaking Medicine Technology:
Cached News: